What is the recommended IV (intravenous) dose of epinephrine for anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Epinephrine Dosing for Anaphylaxis

For anaphylaxis, the recommended IV epinephrine dose is 0.05-0.1 mg (using 1:10,000 solution) administered slowly over several minutes, and should only be used when patients have failed to respond to intramuscular epinephrine and volume resuscitation. 1

Indications for IV Epinephrine

IV epinephrine should be reserved for specific situations:

  • Profound hypotension despite fluid resuscitation
  • Anaphylaxis not responding to IM epinephrine and volume resuscitation
  • Continued shock after volume resuscitation
  • Cardiac arrest during anaphylaxis

Proper IV Administration Protocol

  1. Preparation: Use 1:10,000 solution (0.1 mg/mL)
  2. Initial dose: 0.05-0.1 mg administered slowly over several minutes
  3. Alternative preparation method: Dilute 1 mg (1 mL) of 1:1000 epinephrine in 10 mL normal saline (yields 0.1 mg/mL) 2

Continuous Infusion Option

For ongoing anaphylaxis requiring sustained treatment:

  • Standard preparation: Add 1 mg (1 mL) of 1:1000 epinephrine to 250 mL D5W (concentration: 4.0 μg/mL)
  • Initial rate: 1-4 μg/min (15-60 drops/min with microdrop apparatus)
  • Maximum rate: 10.0 μg/min
  • Alternative preparation: 1:100,000 solution (1 mg in 100 mL saline) at 30-100 mL/h (5-15 μg/min) 2

Pediatric Dosing

  • IV bolus: 0.01 mg/kg using 1:10,000 solution (maximum 0.3 mg) 2
  • "Rule of 6" for infusion: 0.6 × body weight (kg) = mg of epinephrine diluted to 100 mL; then 1 mL/hr delivers 0.1 μg/kg/min 1

Critical Safety Considerations

  • Continuous monitoring is essential: ECG, blood pressure (every minute during initial titration), and pulse oximetry 1
  • High-risk setting: IV epinephrine carries significant risk of potentially lethal arrhythmias 2, 3
  • Limited setting use: Only administer IV epinephrine without hemodynamic monitoring if deemed absolutely essential after failure of several epinephrine injections 2
  • Overdose risk: IV bolus administration has 61.3 times higher risk of overdose compared to IM administration 3
  • Cardiovascular complications: IV bolus carries 8.7 times higher risk of adverse cardiovascular events than IM administration 3

Cardiac Arrest During Anaphylaxis

For cardiopulmonary arrest during anaphylaxis, higher doses are used:

  • 1-3 mg (1:10,000) slowly IV over 3 minutes
  • Followed by 3-5 mg IV over 3 minutes
  • Then 4-10 mg/min infusion 2

First-Line Treatment Reminder

Remember that IM epinephrine (0.3-0.5 mg of 1:1000 solution for adults, 0.01 mg/kg for children) in the lateral thigh is the first-line treatment for anaphylaxis 1, 4. IV administration should only be considered when:

  • Patient has failed to respond to IM doses
  • Patient has profound hypotension
  • Patient is in cardiac arrest

Common Pitfalls to Avoid

  • Dosing confusion: Mistaking cardiac arrest dosing (1 mg IV) for anaphylaxis dosing can cause severe complications 5
  • Delayed administration: Delays in epinephrine administration increase mortality risk 6
  • Route confusion: Using IV when IM would be more appropriate and safer 3
  • Overreliance on antihistamines: These are second-line agents and should never replace epinephrine 2, 6
  • Inadequate monitoring: Failing to monitor for cardiovascular complications during IV administration 1

Early and appropriate epinephrine administration is crucial for successful anaphylaxis management, but the route and dose must be carefully selected to maximize benefit while minimizing potentially serious cardiovascular risks.

References

Guideline

Epinephrine Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The role of epinephrine in the treatment of anaphylaxis.

Current allergy and asthma reports, 2003

Research

Managing anaphylaxis: Epinephrine, antihistamines, and corticosteroids: More than 10 years of Cross-Canada Anaphylaxis REgistry data.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.